View Single Post
Old 15-12-2017, 11:56 AM   #20
Senior Member
Join Date: Apr 2015
Posts: 2,678
Likes: 560 (294 Posts)

Originally Posted by the tealady View Post
I have heard about the theory.
You collect tumour and blood samples and go through a long process to create the vaccine (some of which is explained in the following link) This is needed to try and identify the patients' own neoantigens, or newly formed antigens that are often found in cancer cells but usually haven't been recognised by the immune system. The contents of the vaccines are taken up by antigen presenting cells and educate certain T-cells to recognise and attack specific targets on the cancer cells and thereby kill them. What makes these an attractive target is that they (neoantigens) are seen as ''foreign'' to the immune system so there should be no tolerance (central or peripheral). Responses to them also drive checkpoint inhibitor efficacy

However a number of problems need to be overcome. The current in silico approaches have limited ability to predict the right neoantigens for both CD4+ (~5%) and CD8+ (~20%) T-cells The former help expand and enhance the function of CD8+ T-cells, mediate tumour-associated macrophage repolarisation, have antiangiogenic effects and other antitumour immune mechanisms
''Chlorine is a deadly poison gas employed on European battlefields in World War I. Sodium is a corrosive metal which burns upon contact with water. Together they make a placid and unpoisonous material, table salt. Why each of these substances has the properties it does is a subject called chemistry'' - Carl Sagan

Why is it that the loudest critics of ''Big Pharma'' are Big Placebo?

Last edited by dumbcritic; 15-12-2017 at 12:05 PM.
dumbcritic is offline   Reply With Quote